In addition to CS, it is well known that HS and HS-modified proteoglycans (HSPGs), such as syndecan and glypican, are expressed in melanoma, breast cancer, glioma, and hepatocellular carcinoma and are related to cancer growth and metastasis (20, 21). Here, SDC1 is linked to hepatocellular carcinoma.